Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis

被引:55
作者
Li, SK [1 ]
Jeong, EK
Hastings, MS
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Utah Ctr Adv Imaging Res Radiol, Salt Lake City, UT USA
[3] Aciont Inc, Salt Lake City, UT USA
关键词
D O I
10.1167/iovs.03-0821
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. The objectives were to determine by nuclear magnetic resonance imaging (MRI) the target sites of ion delivery in the eye during iontophoresis, compare transscleral and transcorneal ocular iontophoresis, and monitor the distribution of a probe ion in the anterior chamber and vitreous after iontophoretic delivery. METHODS. Thirty-minute 2-mA anodal constant current transscleral and transcorneal iontophoresis ( current density, 10 mA/ cm(2)) was performed on three New Zealand White rabbits in vivo. Intravitreal injection and passive delivery were the controls. Transscleral and transcorneal iontophoresis experiments were conducted with the electrode device placed in the superior cul-de-sac away from the limbus and on the cornea adjacent to the limbus, respectively. During iontophoresis, the current delivered into the eye was monitored using a probe ion (Mn2+) with MRI. The distributions of the ion in the aqueous and vitreous humor after iontophoresis, passive delivery, and intravitreal injection were also determined by MRI. RESULTS. With the short application time, passive diffusion did not deliver a significant amount of the ion into the eye. Whereas transscleral iontophoresis delivered the ion into the vitreous, transcorneal iontophoresis delivered the ion into the anterior chamber. The current pathways during iontophoresis were mainly from the electrode into the eye, perpendicular to the electrode - eye interface beneath the electrode. Electric current along the surface of the globe was relatively minimal. With the present transscleral iontophoresis protocol, the ion penetrated the sclera and traveled as far as 1.5 mm from the electrode - conjunctiva interface into the vitreous. For transcorneal iontophoresis, the ion penetrated the cornea and filled the entire anterior chamber. CONCLUSIONS. MRI can be a useful technique in the study of the penetration of probe compounds in the eye during and after iontophoresis, such as in iontophoresis protocol and device testing. Ocular pharmacokinetic studies using MRI are noninvasive and provide real-time data without perturbation and compound redistribution that can occur during dissection and assay in traditional pharmacokinetic studies. With MRI, it was shown that transscleral iontophoresis, transcorneal iontophoresis, intravitreal injection deliver ions to different parts of the eye.
引用
收藏
页码:1224 / 1231
页数:8
相关论文
共 27 条
  • [1] Alikacem N, 2000, INVEST OPHTH VIS SCI, V41, P1561
  • [2] BARD AJ, 1980, ELECTROCHEMICAL METH
  • [3] BARZA M, 1987, INVEST OPHTH VIS SCI, V28, P893
  • [4] Transscleral Coulomb-controlled iontophoresis of methyl prednisolone into the rabbit eye: Influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels
    Behar-Cohen, FF
    El Aouni, A
    Gautier, S
    David, G
    Davis, J
    Chapon, P
    Parel, JM
    [J]. EXPERIMENTAL EYE RESEARCH, 2002, 74 (01) : 51 - 59
  • [5] Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats
    BeharCohen, FF
    Parel, JM
    Pouliquen, Y
    ThillayeGoldenberg, B
    Goureau, O
    Heydolph, S
    Courtois, Y
    DeKozak, Y
    [J]. EXPERIMENTAL EYE RESEARCH, 1997, 65 (04) : 533 - 545
  • [6] Crank J., 1979, MATH DIFFUSION
  • [7] Transscleral drug delivery for posterior segment disease
    Geroski, DH
    Edelhauser, HF
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2001, 52 (01) : 37 - 48
  • [8] GROSSMAN RE, 1990, INVEST OPHTH VIS SCI, V31, P909
  • [9] Hamalainen KM, 1997, INVEST OPHTH VIS SCI, V38, P627
  • [10] Polar solute transport across the pigmented rabbit conjunctiva: Size dependence and the influence of 8-bromo cyclic adenosine monophosphate
    Horibe, Y
    Hosoya, K
    Kim, KJ
    Ogiso, T
    Lee, VHL
    [J]. PHARMACEUTICAL RESEARCH, 1997, 14 (09) : 1246 - 1251